Raymond J Kim Selected Research

Raymond J Kim Research Topics

Disease

17	Infarction (Infarctions) 10/2021 - 07/2002
15	Myocardial Infarction 01/2021 - 10/2002
11	Heart Failure 01/2021 - 10/2003
8	ST Elevation Myocardial Infarction 01/2022 - 08/2010
7	Cicatrix (Scar) 01/2021 - 12/2002
6	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 02/2004
5	Chest Pain (Chest Pains) 10/2021 - 09/2009
5	Left Ventricular Dysfunction 01/2021 - 01/2005
3	Fibrosis (Cirrhosis) 05/2020 - 12/2010
2	Neoplasms (Cancer) 01/2021 - 01/2019
2	Thrombosis (Thrombus) 01/2019 - 05/2011
2	Cardiomyopathies (Cardiomyopathy) 04/2018 - 01/2017
2	Necrosis 04/2018 - 02/2003
2	Inflammation (Inflammations) 04/2018 - 01/2017
2	Ischemia 04/2017 - 11/2010
2	Reperfusion Injury 11/2013 - 10/2012
2	Ventricular Remodeling 05/2011 - 11/2010
2	Cardiac Sudden Death (Sudden Cardiac Arrest) 02/2011 - 06/2007
1	Cardiogenic Shock 01/2022
1	COVID-19 10/2021
1	Myocarditis (Carditis) 10/2021
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Heart Neoplasms 01/2021
1	Non-ST Elevated Myocardial Infarction 01/2021
1	Ischemic Stroke 12/2018
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 10/2018
1	Infections 04/2018
1	Thrombophilia 04/2018
1	Hypotension (Low Blood Pressure) 01/2016
1	Mitral Valve Insufficiency (Mitral Regurgitation) 09/2014
1	Edema (Dropsy) 10/2012
1	Stroke (Strokes) 05/2011
1	Endomyocardial Fibrosis 05/2011
1	Glycogen Storage Disease Type II (Pompe's Disease) 12/2010
1	Lysosomal Storage Diseases (Lysosomal Storage Disease) 12/2010
1	Hyperlipidemias (Hyperlipidemia) 09/2010
1	Shock 11/2009
1	Coronary Disease (Coronary Heart Disease) 09/2006
1	Coronary Occlusion 06/2004
1	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 05/2003
1	Death (Near-Death Experience) 05/2003

Drug/Important Bio-Agent (IBA)

15	GadoliniumIBA 10/2021 - 12/2002
6	Biomarkers (Surrogate Marker)IBA 10/2021 - 12/2009
3	TroponinIBA 11/2019 - 09/2010
3	Adenosine (Adenocard)FDA LinkGeneric 01/2017 - 04/2006
3	Erythropoietin FDA Link 11/2013 - 11/2010
3	pexelizumabIBA 02/2013 - 01/2010
2	Vasodilator Agents (Vasodilators)IBA 01/2022 - 01/2019
2	Troponin T (Troponin T1)IBA 01/2021 - 11/2019
2	Pharmaceutical PreparationsIBA 01/2017 - 01/2016
2	EnzymesIBA 09/2009 - 10/2002
2	MB Form Creatine KinaseIBA 02/2008 - 10/2002
2	Gadolinium DTPA (Magnevist)FDA Link 02/2003 - 07/2002
1	Messenger RNA (mRNA)IBA 10/2021
1	VaccinesIBA 10/2021
1	Contrast MediaIBA 10/2021
1	Smallpox Vaccine (Vaccine, Smallpox)FDA Link 10/2021
1	arginyl- 2,'6'- dimethyltyrosyl- lysyl- phenylalaninamideIBA 05/2020
1	Chymases (Chymase)IBA 01/2020
1	fulacimstatIBA 01/2020
1	omega-Chloroacetophenone (Mace)IBA 12/2018
1	Cell Surface ReceptorsIBA 04/2018
1	SodiumIBA 10/2017
1	CreatinineIBA 10/2017
1	neladenoson bialanateIBA 01/2017
1	Adenosine A1 ReceptorIBA 01/2017
1	trans-crotonin (CTN)IBA 12/2013
1	erucylphosphocholineIBA 11/2013
1	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 03/2013
1	Epoetin Alfa (Epogen)FDA Link 05/2011
1	GlucosidasesIBA 12/2010
1	AcidsIBA 12/2010
1	C-Reactive ProteinIBA 09/2010
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 09/2010
1	pro-brain natriuretic peptide (1-76)IBA 08/2010
1	gadoversetamide (OptiMARK)FDA Link 02/2008
1	diethylenetriamineIBA 05/2006
1	CollagenIBA 04/2005
1	C.I. direct red 80IBA 04/2005
1	N(2)-(3-trifluoromethylphenyl)guanineIBA 04/2004
1	MB 3 (MB-3)IBA 04/2004
1	Simvastatin (Zocor)FDA LinkGeneric 02/2004
1	Dobutamine FDA LinkGeneric 02/2003
1	Technetium Tc 99m Sestamibi (Cardiolite)FDA LinkGeneric 10/2002

Therapy/Procedure

13	Therapeutics 01/2021 - 10/2003
7	Percutaneous Coronary Intervention 01/2022 - 01/2010
4	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 01/2021 - 02/2011
2	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 12/2018 - 02/2004
2	Defibrillators (Defibrillator) 07/2012 - 11/2009
2	Stents 05/2011 - 09/2006
1	Art Therapy 04/2018
1	Intravenous Administration 01/2017
1	Prostheses and Implants (Prosthesis) 09/2014
1	Enzyme Replacement Therapy 12/2010